QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Socinski, Mark A.;  Spira, Alexander I.;  Paz-Ares, Luis G.;  Reck, Martin;  Lu, Shun 收藏  |  浏览/下载：31/0  |  提交时间：2022/01/10 EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study 期刊论文 2017, 卷号: 113, 页码: 37-44 作者:  Han, Baohui;  Tjulandin, Sergei;  Hagiwara, Koichi;  Normanno, Nicola;  Wulandari, Laksmi 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Adenocarcinoma  Circulating free tumour-derived DNA  Diagnostic  Epidermal growth factor receptor  Non-small-cell lung cancer   Local Diagnostic Practices for Advanced Non-Small-Cell Lung Cancer in Asia-Pacific and Russia: IGNITE Study 期刊论文 2015, 卷号: 10, 期号: 9, 页码: S466-S467 作者:  Tjulandin, Sergei;  Han, Baohui;  Hagiwara, Koichi;  Normanno, Nicola;  Wulandari, Laksmi 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 NSCLC  EGFR mutation  diagnostic practices   Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer Safety of Avastin in Lung trial (MO19390) 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2012, 卷号: 7, 期号: 1 作者:  Laskin, Janessa;  Crino, Lucio;  Felip, Enriqueta;  Franke, Fabio;  Gorbunova, Vera 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Bevacizumab  Vascular endothelial growth factor  Safety  Elderly  Non-small cell lung cancer (NSCLC)